Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum
Journal of the American Society for Mass Spectrometry · 2023
DOI: 10.1021/jasms.3c00064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2023. Verfasst von Nicole A Schneck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Development, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
LC-MS analysis of therapeutic antibodies and other biotherapeutics from in-life studies (e.g., serum/plasma) has evolved from simple peptide digestion to peptide mapping and intact mass monitoring. From more advanced analytical approaches, a deeper understanding as to the fate of the biotherapeutic in vivo is gained. Here, we examine the next generation of approaches to facilitate the most comprehensive understanding of large molecule drug fate in circulation. Three case studies are presented: (1) use of relative and absolute calibration curves for biotherapeutic quantitation from the same sample set; (2) top-down mass spectrometry applied to bioanalytical assays; (3) biotherapeutic protein complexes from serum analyzed by native protein MS. We anticipate that these approaches will be further adapted and applied by other research groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Analytical Development, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States.
- Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States.
ORCID-Profile: John F Kellie
Zitieren
APA
Schneck, N. A., Mehl, J. T., & Kellie, J. F. (2023). Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.3c00064
Vancouver
Schneck NA, Mehl JT, Kellie JF. Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum. Journal of the American Society for Mass Spectrometry. 2023. doi:10.1021/jasms.3c00064
BibTeX
@article{Schneck2023,
author = {Schneck, Nicole A and Mehl, John T and Kellie, John F},
title = {Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2023},
doi = {10.1021/jasms.3c00064}
}
EUVIMED